NYMC > News and Events > NYMC in the News

Dissolving Film Quells Agitation in Schizophrenia, Bipolar Disorder

May 04, 2021

In the first trial of 380 patients with schizophrenia, treatment with 120 µg of the oral rapidly dissolving film yielded an average 8.5-point reduction in Positive and Negative Syndrome Scale (PANSS)

NYMC Faculty news: Leslie L. Citrome, M.D., M.P.H., clinical professor of psychiatry and behavioral sciences 

Source: Medically Prime